AgomAb Therapeutics (SA)
Active
VAT
BE 0674.527.310
Commercial name
Agomab
Address
Posthoflei 1/6
2600
Antwerpen
Established
13-04-2017
Principal activity
Research and experimental development on biotechnology
Crisis resilience of AgomAb Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of AgomAb Therapeutics
2022
|
2021
|
2020
|
2019
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | -€9,396,576 | -45% |
-€6,484,466 | -1% |
-€6,419,575 | -110% |
-€3,050,214 |
| Equity | €96,919,958 | 43% |
€67,933,769 | 426% |
€12,918,235 | 95% |
€6,620,141 |
| Gross margin | €993,210 | 119% |
-€5,325,621 | 15% |
-€6,232,654 | -116% |
-€2,887,478 |
| Employees | 10,1 FTE | 166% |
3,8 FTE | 280% |
1 FTE | 0% |
1 FTE |
Publications in the Belgian Official Journal for AgomAb Therapeutics
Frequently asked questions
What is the VAT number of AgomAb Therapeutics?
The VAT number of AgomAb Therapeutics is BE0674527310.
When was AgomAb Therapeutics founded?
AgomAb Therapeutics was founded on 13-04-2017.
What is the address of AgomAb Therapeutics?
The current registered office of AgomAb Therapeutics is located at Posthoflei 1/6, 2600 Antwerpen.
When was the last time AgomAb Therapeutics filed their annual financial statements?
The most recent financial statements of AgomAb Therapeutics were filed on 07-07-2023. You can view them here.
How many employees does AgomAb Therapeutics have?
There are 10,1 FTEs working at AgomAb Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of AgomAb Therapeutics?
At the time of its most recent financial statements, AgomAb Therapeutics did not publish any turnover figures. AgomAb Therapeutics reported a gross margin of €993,210.06.
